Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 5

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 5
---
company” as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and have
elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus is a
part and in documents that are incorporated herein by reference and may elect to take advantage of other reduced reporting requirements
in our future filings with SEC. As a result, the information that we provide to our shareholders may be different than you might receive
from other public reporting companies in which you hold equity interests.

#### Corporate Information
We are a British Columbia, Canada corporation
founded in 2007. We operate through our wholly owned subsidiaries, Edesa Biotech Research, Inc., an Ontario, Canada corporation, and Edesa
Biotech USA, Inc., a California, USA corporation. In June 2019, we acquired the Ontario corporation through a reverse acquisition and
changed our name to Edesa Biotech, Inc. Our common shares are traded on the Nasdaq Capital Market under the symbol “EDSA.”
Our executive offices are located at 100 Spy Court, Markham, Ontario L3R 5H6 Canada and our telephone number at this location is (289)
800-9600. Our website address is www.edesabiotech.com. The information contained on, or that can be accessed through, our website is not
a part of this prospectus. Our trademarks and trade names include, but may not be limited to, “Edesa Biotech,” and the Edesa
logo.

| 3 |

### THE OFFERING
| Common Shares offered by the Selling Shareholders |     | Up to 7,812,496 common shares, which are comprised of (i) 3,468,746 Shares and (ii) 4,343,750 Conversion Shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Common Shares outstanding as of February 28, 2025 |     | 6,992,625 common shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Selling Shareholders                              |     | All of the shares are being offered by the Selling Shareholders named herein. See “Selling Shareholders” on page 8 of this prospectus for more information on the Selling Shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Listing information                               |     | Our common shares are listed on the Nasdaq Capital Market under the symbol “EDSA.”                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Use of